Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
360
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
October 29, 2019
0Primary Completion Date
March 6, 2020
0Study Completion Date
March 6, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Intervention Name
Placebo0
LY34718510
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3471851 in Japanese and Caucasian Healthy Subjects0
Last Updated
November 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Participant0
Investigator0
Study summary
The main purpose of this study is to explore the safety and tolerability of LY3471851 in healthy Japanese and Caucasian participants. The study will also estimate how much LY3471851 gets into the blood stream and how long it takes the body to remove it. The study is expected to last about 7 weeks for each participant.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
